Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Crossref DOI link: https://doi.org/10.1007/s00277-014-2215-9
Published Online: 2014-09-18
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salihoglu, A.
Elverdi, T.
Karadogan, I.
Paydas, S.
Ozdemir, E.
Erdem, G.
Karadurmus, N.
Akyol, G.
Kaynar, L.
Yegin, ZA
Sucak, G.
Ozkocaman, V.
Topcuoglu, P.
Ozcan, M.
Birtas, E.
Goker, H.
Baslar, Z.
Ferhanoglu, B.
License valid from 2014-09-18